Factors associated with adherence to screening before diagnosis of hepatocellular carcinoma related to chronic hepatitis B
JIE Bin*, BAI Chunhua, BI Huaqiang, QIU Yan
*Department of Military Developmental Psychology, School of Psychology, Army Medical University (Third Military Medical University), Chongqing 400038, China
Abstract：Objective To investigate the factors associated with the patient's adherence to screening in the five years before the diagnosis of hepatocellular carcinoma (HCC) related to chronic hepatitis B ( CHB ), so as to provide reference for improving the screening rate. Methods From June 2016 to April 2018, the patients with newly diagnosed HCC and a history of CHB for more than five years in Southwest Hospital in Chongqing were interviewed. The information about socio-demographic characteristics, health status, medical care and HCC screening in the past five years were collected. A multivariate logistic regression model was used to analyze the factors associated with adherence to screening. Results Among 420 participants, 140 ( 33.33% ) adhered to HCC screening, 124 ( 29.53% ) had irregular/incomplete screening, while 156 ( 37.14% ) never had screening. The proportion of early-stage HCC at diagnosis was significantly higher in patients who adhered to screening ( 77.14% ) than that in patients who had irregular/incomplete screening (35.48%) or no screening ( 12.82% ) and the differences were statistically significant ( P<0.05 ). The multivariate analysis demonstrated that five factors were significantly associated with patient's adherence to screening, including education level of high school and above ( OR=2.346, 95%CI: 1.370-4.017), family history of HCC ( OR=2.795, 95%CI: 1.457-5.362 ), history of chronic diseases ( OR=3.860, 95%CI: 2.052-7.262), acceptance of antiviral therapy ( OR=17.816, 95%CI: 9.702-32.716 ) and specialized clinic visits ( OR=8.332, 95%CI: 1.588-43.710 ). Conclusions Adherence to screening is conducive to the early detection of HCC, but the screening rate is low in the patients with CHB. Education level, history of HCC, health status and medical status are significantly related to screening adherence.
揭彬, 白春花, 毕华强, 邱琰. 乙肝患者肝癌诊断前规范筛查的影响因素分析[J]. 预防医学, 2021, 33(5): 433-437.
JIE Bin, BAI Chunhua, BI Huaqiang, QIU Yan. Factors associated with adherence to screening before diagnosis of hepatocellular carcinoma related to chronic hepatitis B. Preventive Medicine, 2021, 33(5): 433-437.
[1] SINGAL A G,PILLAI A,TIRO J.Early detection,curative treatment,and survival rates for hepatocellular carcinoma surveillance in patients with cirrhosis:a meta-analysis[J]. PLoS Med,2014,11:e1001624. [2] 中华医学会肝病学分会,中华医学会感染病学分会. 慢性乙型肝炎防治指南(2015年更新版)[J]. 中华肝脏病杂志,2015,23(12):888-905. [3] 丁惠国. 重视原发性肝癌的规范化筛查与监测[J]. 北京医学,2013,35(6):409-411. [4] WANG C,CHEN V,VU V,et al.Poor adherence and low adherence rates or hepatocellular carcinoma surveillance in patients with chronic hepatitis B[J]. Medicine(Baltimore),2016,95(35):e4744. [5] 陈建国,张永辉,朱健,等. 启东肝癌的早诊早治及筛查效果评价[J]. 肿瘤杂志,2017,23(12):946-951. [6] 于慧会,任英,张亮,等. 2014—2018年辽宁省城市居民肝癌筛查结果分析[J]. 现代预防医学,2020,47(5):913-916. [7] XU K,WATANABE-GALLOWAY S,ROCHLING F A,et al.Practice,knowledge,and barriers for screening of hepatocellular carcinoma among high-risk Chinese patients[J]. Ann Glob Health,2017,83(2):281-292. [8] LI D J,PARK Y,VACHHARAJANI N,et al.Physician-patient communication is associated with hepatocellular carcinoma screening in chronic liver disease patients[J]. J Clin Gastroenterol,2017,51(5):454-460. [9] AHMED-MOHAMMED H A,YANG J D,GIAMA N H,et al. Factors influencing surveillance for hepatocellular carcinoma in patients with liver cirrhosis[J]. Liver Cancer,2017,6(2):126-136. [10] NAM J Y,LEE J H,KIM H Y,et al.Oral medications enhance adherence to surveillance for hepatocellular carcinoma and survival in chronic hepatitis B patients[J]. PLoS One,2017,12(1):e0166188. [11] 苏中华,郝伟,谌红献. 中国五地区饮酒情况及相关问题调查Ⅰ.普通人群的饮酒状况[J]. 中国心理卫生杂志,2003,17(8):536-539. [12] 中华人民共和国国家卫生和计划生育委员会. 原发性肝癌诊疗规范(2017年版)[J]. 中国实用外科杂志,2017,37(7):705-720. [13] European Association for the Study of the Liver. EASL-EORTC clinical practice guidelines:management of hepatocellular carcinoma[J]. J Hepatol,2012,56:908-943. [14] Al HASANI F,KNOEPFLI M,GEMPERLI A,et al.Factors affecting screening for hepatocellular carcinoma[J]. Ann Hepatol,2014,13(2):204-210. [15] 中华人民共和国教育部.中国教育统计年鉴2017[M].北京:中国统计出版社,2018. [16] 于慧会,吕广艳,庞景国,等. 辽宁省建平地区7 338例肝癌高危人群肝脏超声筛查结果分析[J]. 肿瘤学杂志,2017,23(11):1004-1006. [17] 罗小敏,陈清锋,赵美萍,等. 奉化市社区慢性乙型肝炎特定人群早期肝癌筛查追踪[J]. 中国预防医学杂志,2018,19(9):664-667. [18] El-SERAG H B,ALSARRAJ A,RICHARDSON P,et al. Hepatocellular carcinoma screening practices in the Department of Veterans Affairs:findings from a national facility survey[J]. Dig Dis Sci,2013,58:3117-3126.
